Uncovering the role of middle managers in the implementation of - - PowerPoint PPT Presentation

uncovering the role of middle managers in the
SMART_READER_LITE
LIVE PREVIEW

Uncovering the role of middle managers in the implementation of - - PowerPoint PPT Presentation

Uncovering the role of middle managers in the implementation of innovations in cancer care Robin Urquhart, PhD Assistant Professor, Department of Surgery, Dalhousie University Affiliate Scientist, Nova Scotia Health Authority Senior Scientist,


slide-1
SLIDE 1

Uncovering the role of middle managers in the implementation of innovations in cancer care

Robin Urquhart, PhD

Assistant Professor, Department of Surgery, Dalhousie University Affiliate Scientist, Nova Scotia Health Authority Senior Scientist, Beatrice Hunter Cancer Research Institute robin.urquhart@nshealth.ca @UrquhartRobin

slide-2
SLIDE 2

Learning objectives

  • 1. Understand the substantive role middle

managers play in implementation processes

  • 2. Identify factors influencing their commitment

to innovation implementation

  • 3. Consider potential strategies to optimize their

role in innovation implementation

slide-3
SLIDE 3

Today

  • Definitions
  • Emerging literature
  • Recent study
  • Wrap up & questions
slide-4
SLIDE 4

Definitions

Middle managers: employees who are supervised by an

  • rganization’s top managers and who supervise frontline

employees1 Innovation: an idea, technology, or practice that an

  • rganization is using for the first time2

Implementation: the transition period that follows the decision to adopt “during which targeted organizational members ideally become increasingly skilled, consistent, and committed in their use of an innovation”2

slide-5
SLIDE 5

Why middle managers?

slide-6
SLIDE 6
slide-7
SLIDE 7

Facilitating influence

  • Explicitly demonstrating moral support for implementation
  • Exerting authority over existing departmental policies, priorities, & resources
  • Influencing development of new policy related to the innovation

Impeding or undermining influence

  • Choose other priorities, limit resources
  • Ensure that implementation was something carried out ‘off the side of one’s desk’
slide-8
SLIDE 8

State of knowledge

  • Middle managers’ role has received scarce attention
  • Focus on senior (executive) leadership and frontline

clinicians

  • +++ evidence in non‐health sectors of influence on

implementation & organizational performance3‐6

  • Commitment to implementation linked to implementation

speed, strategy realization, productivity, enhanced competitiveness

  • Positive or negative4
slide-9
SLIDE 9

State of knowledge cont’d

Floyd & Wooldridge4,5,7,8

  • Consider implementation role of middle managers as

most important

  • Implementation not solely carrying out top

management intentions, but an adjustment of org priorities & directions to emergent issues

slide-10
SLIDE 10

State of knowledge cont’d

  • Evidence from health care8.9 that performance is

related to what happens at mid level of organization

  • Several studies exploring middle managers’ support

for innovation implementation in health care

slide-11
SLIDE 11
slide-12
SLIDE 12

Reasons for non‐support:

  • Inadequate understanding of the vision or intent of framework
  • Limited involvement in framework development process
  • Expected to implement framework with few, if any, additional

resources

slide-13
SLIDE 13

Birken et al1

slide-14
SLIDE 14

Led to study to further examine the (poorly understood) role of middle managers in innovation implementation in health care Funded by CIHR OOGP (MOP# 133398)

slide-15
SLIDE 15

Study aims

  • 1. Explore the role of middle managers in

innovation adoption and implementation in cancer care

  • 2. Identify factors that influence middle

managers’ support of innovation implementation

slide-16
SLIDE 16

Study design & methods

Design: Qualitative study using grounded theory Setting: Nova Scotia (NS) and New Brunswick (NB) Methods: Semi‐structured interviews Participants: Middle managers in the cancer system (clinical care and/or provincial cancer programs)

  • Purposive sampling (maximal variation): training, location
  • Theoretical sampling
  • Data collection cont’d until data saturation reached
slide-17
SLIDE 17

Study findings: participants

17 participants

  • 7 NS, 10 NB
  • 14 with clinical background, 3 non‐clinical

background

  • Range of depts/programs
slide-18
SLIDE 18

Study findings: role

Making it happen

Facilitator,

  • rganizer, planner,

motivator, evaluator

Limited DM power Many roles

  • Translate goals into action
  • Recognize they are part of a team
slide-19
SLIDE 19

Study findings: role cont’d

Making it happen

Facilitator,

  • rganizer, planner,

motivator, evaluator

Limited DM power Many roles

  • Clinical & managerial duties, “spread too thin”
  • Implementation requires additional work &

learning

slide-20
SLIDE 20

Study findings: role cont’d

Making it happen

Facilitator,

  • rganizer, planner,

motivator, evaluator

Limited DM power Many roles

  • Top management makes the “big decisions” &

sets parameters

  • Have to work within these parameters
slide-21
SLIDE 21

How easy will this be? What benefit will it have for patients?

Study findings: support

slide-22
SLIDE 22

How easy will this be? What benefit will it have for patients?

Study findings: support cont’d

Resources

  •  demands not met by

 resources

  • Competing interests &

priorities

  • Resources for staff‐

related costs

  • Ex: staff training
slide-23
SLIDE 23

How easy will this be? What benefit will it have for patients?

Study findings: support cont’d

Fit

  • Alignment with
  • rganizational goals
  • Alignment with current

clinical practice

  • Staff already possess

required knowledge & skills

  • Compatible with

existing IT infrastructure

slide-24
SLIDE 24

How easy will this be? What benefit will it have for patients?

Study findings: support cont’d

Buy‐in

  • Buy‐in from frontline

staff integral How easy/hard will this be?

  • Clinician‐driven

innovations more likely to  staff buy‐in

  • Top managers buy‐in

needed for resources & sign‐off

slide-25
SLIDE 25

How easy will this be? What benefit will it have for patients?

Study findings: support cont’d

  • Responsibility to ensure

patients receive best possible care

  • Evidence for benefit?
  • Does solution address a

local gap?

  • Ex: patient

satisfaction

  • Clinician‐driven more

likely to benefit patients

  • High benefit to patients

≈ high commitment

slide-26
SLIDE 26

Implications

This study suggests

  • Limited involvement in adoption decisions
  • Feel they lack skills/training
  • Facilitate/organize/plan/motivate/evaluate to make it

happen (and in general view it positively) ‐‐‐ potentially important and strategic role that goes beyond mitigating informational gaps May be key link between adoption and implementation

slide-27
SLIDE 27

When organizations adopt innovations, they do so with high expectations, anticipating improvements in organization productivity and

  • performance. However, the adoption of an

innovation does not ensure its implementation; adopted policies may never be put into action, and adopted technologies may sit in unopened crates on the factory floor (p. 1077).2

slide-28
SLIDE 28

Implications cont’d

What are some risks of low middle manager support?

  • ‘Drag their feet’
  • Undermining credibility of implementation
  • Not achieving effective implementation
  • Consistent, committed, skilled use
  • Endangering scale‐up and sustainability
  • Endangering implementation of future innovations
slide-29
SLIDE 29

Implications cont’d

What might be done to support their role?

  • Individual level
  • Involve early on so they understand need for innovation
  • Provide (easy) access to external evidence
  • Mentoring / coaching / skills development
  • Organizational level
  • ‘Networks’ of middle managers (e.g., community of

practice)

slide-30
SLIDE 30

Wrap up

  • Smattering of recent papers
  • Understanding of role & experience of middle

managers remains “remarkably thin”

  • Ripe for further conceptual work & empirical

research

slide-31
SLIDE 31

Questions?

Robin Urquhart (feel free to contact me) robin.urquhart@nshealth.ca @UrquhartRobin Thank you to CIHR for funding this study.

slide-32
SLIDE 32

Reference list

1. Birken SA, Lee SY, Weiner BJ. Uncovering middle managers' role in healthcare innovation

  • implementation. Implement Sci. 2012, 7:28.

2. Klein KJ, Sorra JS. The challenge of innovation implementation. Acad Manage Rev. 1996, 21(4):1055‐80. 3. Mair J. Exploring the determinants of unit performance: the role of middle managers in stimulating profit growth. Group Organ Manage 2005, 2005:263. 4. Floyd SW, Wooldridge B. Managing strategic consensus: the foundation of effective

  • implementation. Aca Manag Exec 1992, 6:27‐39.

5. Floyd SW, Wooldridge B. Dinosaurs or dynamos? Recognizing middle managers strategic

  • role. Acad Manag Exec 1994, 8(4):47‐57.

6. Maritan CA, Brush TH. Heterogeneity and transferring practices: implementing flow manufacturing in multiple plants. Strateg Manag J 2003, 24:945‐959. 7. Floyd SW, Wooldridge B. Middle management involvement in strategy and its association with strategic type: a research note. Strateg Manag J. 1992, 13:153‐67. 8. Floyd SW, Wooldridge B. Middle management’s strategic influence and organizational

  • performance. J Manag Studies 1997, 34(3): 465‐485.

9. Currie G, Proctor SJ. The antecedents of middle managers strategic contribution. The case of a professional bureaucracy. J Manag Studies. 2005; 42(7):1325‐56.